Nautilus Biotechnology Inc. Stock Price, News, Quote & History

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

Nautilus Biotechnology Inc.

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025

Nautilus Biotechnology to Participate in Upcoming September Investor Conferences

Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Nautilus Biotechnology Reports First Quarter 2024 Financial Results

5 US Longevity and Anti-aging Stocks to Watch in 2025

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Latest News

Peloton Closes the First Tranche of Financing and Will Begin Drilling this Month at the North Elko Lithium Project, Nevada

BitMine Immersion Announces ETH Holdings Reaching 3.4 Million Tokens and Total Crypto and Cash Holdings of $13.7 Billion

Drilling at North Peak's Industry Targets Underway. Follow-up Channel Sampling at Dean Cave Complex Stopes Yielded Further High-Grade Gold up to 90.4 g/t

T. ROWE PRICE ANNOUNCES CHIEF OPERATING OFFICER DEPARTURE AND LAUNCH OF NEW TECHNOLOGY, DATA, AND OPERATIONS FUNCTION

SOURCE ROCK ROYALTIES ANNOUNCES ALBERTA CROWN MINERAL RIGHTS LEASING JOINT-VENTURE

Latest News

Outlook Reports world

Featured Biotech Investing Stocks

Browse Companies